| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > FTC Violates Their Own New BUZZ-Marketing Law |
|
Digg It - FTC Violates Their Own New BUZZ-Marketing Law
The Federal Trade Commission FTC is constantly violating its own BUZZ Marketing law According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product , by giving preferential treatment to groups, which “BUZZ” their enforcement action ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in . In fact they totally looked the other way when the Better Business Bureau used fa lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lse and misleading sales tactics in order sign up and charge small businesses $300 here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe lus dollars to join the BBB or Better Business Bureau. In fact the FTC uses BUZZ M d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rketing themselves to misrepresent that their actions help the consumer. Many times ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc their selective, competitive and political prosecution and cases filed are not in easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi act any violation of law, but rather fishing expeditions. The FTC after each case nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically is filed conveniently and Immediately sends out some 8800 Bonzai Buzz press release and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ to attack the company and mislead the public that they are helping them by curbing ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi fraud. In actuality the lies of the FTC are the real fraud on the American People. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a You can tell when the FTC is getting ready to start their next fiscal year or needi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod g additional budget monies from the legislature, as they make up some bogus allegat cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ion that some legitimate company is purporting some sort of Fraud. Such hokum has b tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen come typical of the real endeavors of the Federal Trade Commission. This is not BU t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Z, this is my opinion and as an American I hereby excersize my right to free speech ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust that the FTC wants to take from us. The FTC ought to be ashamed for their BS and b y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nding of the law to extort monies from great companies, while purporting they are h . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de elping consumers, as any fines charged against any company will only come back and elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip aise the prices of the very consumers the claim they are protecting. Think about it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Managing Conflict in the Workplace Finance Accounting Outsourcing Helps to Shed the Workload Getting Ready to Seek Investors
|